Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
norovirus
Biotech
Moderna norovirus trial heads north again in hunt for cases
The timing of the phase 3 readout “will continue to be dependent on case accruals," according to Moderna.
James Waldron
Nov 6, 2025 8:04am
Moderna norovirus vaccine on hold over reported case of GBS
Feb 14, 2025 7:45am
AI drug discoverer's antiviral reduces COVID in mouse lungs
Jan 21, 2025 12:42am
HilleVax stock sinks 80% after norovirus vaccine flunks phase 2
Jul 8, 2024 8:55am
Moderna touts 3 phase 1 data sets to bolster early vax work
Mar 27, 2024 3:21pm
Vaxart norovirus vaccine has mixed success in midphase test
Sep 7, 2023 5:31am
